Golden Valley Development, Inc (GVDI)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2015 | 9.74 Million USD | 2041.11% |
| 2014 | 455.07 Thousand USD | 214.16% |
| 2013 | 144.85 Thousand USD | 0.0% |
| 2011 | 150.31 Thousand USD | -22.91% |
| 2010 | 194.99 Thousand USD | 167.33% |
| 2009 | 72.94 Thousand USD | 31.3% |
| 2008 | 55.55 Thousand USD | 50.96% |
| 2007 | 36.8 Thousand USD | 78.48% |
| 2006 | 20.61 Thousand USD | 371.4% |
| 2005 | 4374.00 USD | 154.68% |
| 2004 | -8000.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2016 Q1 | 1.57 Million USD | -83.79% |
| 2015 Q2 | 341.23 Thousand USD | -20.3% |
| 2015 Q3 | 9.8 Million USD | 2772.38% |
| 2015 Q4 | 9.74 Million USD | -0.59% |
| 2015 FY | 9.74 Million USD | 2041.11% |
| 2015 Q1 | 428.14 Thousand USD | -5.92% |
| 2014 Q4 | 455.07 Thousand USD | 0.0% |
| 2014 FY | 455.07 Thousand USD | 214.16% |
| 2013 FY | 144.85 Thousand USD | 0.0% |
| 2011 FY | 150.31 Thousand USD | -22.91% |
| 2010 Q2 | 82.18 Thousand USD | 6.73% |
| 2010 FY | 194.99 Thousand USD | 167.33% |
| 2010 Q1 | 77 Thousand USD | 5.57% |
| 2009 Q1 | 67.5 Thousand USD | 21.51% |
| 2009 FY | 72.94 Thousand USD | 31.3% |
| 2009 Q4 | 72.94 Thousand USD | 4.73% |
| 2009 Q2 | 65.69 Thousand USD | -2.69% |
| 2009 Q3 | 69.64 Thousand USD | 6.03% |
| 2008 Q1 | 45.77 Thousand USD | 24.39% |
| 2008 Q4 | 55.55 Thousand USD | 4.18% |
| 2008 Q3 | 53.32 Thousand USD | 9.73% |
| 2008 Q2 | 48.6 Thousand USD | 6.17% |
| 2008 FY | 55.55 Thousand USD | 50.96% |
| 2007 Q3 | 19.76 Thousand USD | 109.98% |
| 2007 Q2 | -198.08 Thousand USD | -1111.21% |
| 2007 Q4 | 36.8 Thousand USD | 86.18% |
| 2007 FY | 36.8 Thousand USD | 78.48% |
| 2007 Q1 | 19.58 Thousand USD | -5.0% |
| 2006 Q3 | 93.43 Thousand USD | 2036.1% |
| 2006 Q2 | 4374.00 USD | -91.76% |
| 2006 Q1 | 53.11 Thousand USD | 1114.27% |
| 2006 FY | 20.61 Thousand USD | 371.4% |
| 2006 Q4 | 20.61 Thousand USD | -77.93% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | 4374.00 USD | 154.68% |
| 2005 Q3 | 760.00 USD | 0.0% |
| 2005 Q4 | 4374.00 USD | 475.53% |
| 2004 FY | -8000.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 100.0% |
| Ansell Limited | -54.99 Million USD | 100.0% |
| Ansell Limited | -55.1 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | -36.49 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | -105.1 Thousand USD | 100.0% |
| Psykey, Inc. | 634.59 Thousand USD | 100.0% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.0% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.0% |
| Encision Inc. | 1.29 Million USD | 100.0% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 100.0% |
| Innovative MedTech Inc. | 1.76 Million USD | 100.0% |
| LifePoint, Inc. | -3.26 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | -43.3 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | -1.03 Million USD | 100.0% |
| SmileDirectClub, Inc. | 778.67 Million USD | 100.0% |
| Sector 10, Inc. | 163 Thousand USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.0% |
| SheerVision, Inc. | 57.34 Thousand USD | 100.0% |
| United Health Products, Inc. | 660.56 Thousand USD | 100.0% |
| Vasamed, Inc. | 22.12 Thousand USD | 100.0% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 100.0% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 100.0% |